🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The MS-CEBA Study: Determining Cognitive, Energetic, Behavioural and Affective (CEBA) Profiles in Multiple Sclerosis

Recruitingn/aAges 18 Years - 70 YearsAllUniversity Medical Center Groningen
NCT06016309 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Multiple Sclerosis (MS) is an invalidating neurological disease known to cause physical symptoms, which usually are the main focus of treatment. However, non-physical, more neuropsychological, symptoms also frequently occur, concerning the Cognitive, Energetic, Behavioural and Affective (CEBA) domains. Symptoms in the CEBA domains are known to negatively affect societal participation, and thereby quality of life. Unfortunately, despite their negative consequences, CEBA symptoms are not always timely recognized in people with MS (pwMS). Moreover, despite the fact that there are various effective neuropsychological treatments available for neurological patients with these symptoms, most pwMS do not yet receive these treatments. Although findings in group studies confirm that each of the CEBA domains can be affected in pwMS and correlations between symptoms regarding different CEBA domains

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
In order to be eligible to participate in this study, a patient must meet all of the following criteria: Inclusion Criteria: * Confirmed MS diagnosis (all subtypes); * Age18-70; * Adequate command of the Dutch language. Exclusion Criteria: * Not being able to participate in a short neuropsychological assessment (NPA) as judged by the MS clinician and/or investigator; * Presence of any other neurological and/or major psychiatric condition. The group of HC's will be matched to the patient group on age and education level.
💊

What it tests

  • There is no intervention.
📍

Where

1 site
University Medical Center Groningen (UMCG)
Groningen, Netherlands
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy